Loading
A phase 3 trial of Cyclophosphamide, Cytarabine, Daunorubicin, Dexamethasone, Doxorubicin, Etoposide, Ifosfamide, Mercaptopurine, Methotrexate, Prednisone, Thioguanine, Vincristine, Vindesine and Fludarabine in Leukaemia, run by University Hospital Schleswig-Holstein, completed.
International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia is a phase 3 interventional study registered as NCT01117441 by University Hospital Schleswig-Holstein, with 6136 participants recorded, started 2010-06 and reaching its primary completion in 2021-12-31. Interventions recorded: PEG-L-asparaginase, cyclophosphamide, cytarabine, daunorubicin hydrochloride, dexamethasone, doxorubicin hydrochloride, etoposide, ifosfamide, mercaptopurine, methotrexate, prednisone, thioguanine, vincristine sulfate, vindesine, daunoxome, fludarabine, Radiation Therapy. Conditions recorded: Leukemia.
Linked to the drug Vindesine because the registry names it among its interventions and Leukaemia among its conditions. Registry record only: no result has been read by an editor.
Shares Vindesine, Cytarabine, Ifosfamide, Methotrexate and the tag pipeline.
Shares Thioguanine, Mercaptopurine, Daunorubicin, Cytarabine and the tag pipeline.
Shares Thioguanine, Mercaptopurine, Daunorubicin, Cytarabine and the tag pipeline.
Shares Mercaptopurine, Daunorubicin, Cytarabine, Methotrexate and the tag pipeline.
Shares Daunorubicin, Cytarabine, Prednisone, Dexamethasone and the tag pipeline.
Shares Cytarabine, Methotrexate, Prednisone, Vincristine and the tag pipeline.
Shares Thioguanine, Daunorubicin, Cytarabine, Etoposide and the tag pipeline.
Shares Mercaptopurine, Cytarabine, Methotrexate, Dexamethasone and the tag pipeline.